收藏切换
The theory of "body−viscera combined obstruction" from the perspective of state−target medicine and its clinical application in essential hypertension
收藏切换
PDF
Nan JIANG1, Ciming PAN2, 3, Hui FANG1, Changwu DONG4, *
Science & Technology Review | 2026, 44(13) : 151 - 156
Less
收藏切换
Science & Technology Review | 2026, 44(13): 151-156
Papers
The theory of "body−viscera combined obstruction" from the perspective of state−target medicine and its clinical application in essential hypertension
Full
Nan JIANG1, Ciming PAN2, 3, Hui FANG1, Changwu DONG4, *
Affiliations
  • 1College of Traditional Chinese Medicine, Anhui University of Chinese Medicine, Hefei 230038, China
  • 2School of Life Sciences, Yunnan University, Kunming 650500, China
  • 3Yunzhongdao Yunnan Traditional Chinese Medicine Great Health Co., Ltd., Kunming 650500, China
  • 4The Second Affiliated Hospital of Anhui University of Chinese Medicine, Hefei 230038, China
Published: 2026-07-13 doi: 10.3981/j.issn.1000-7857.2025.12.00004
Outline
收藏切换

Essential hypertension, as a common chronic cardiovascular syndrome, shares inherent similarities with rheumatic immune diseases in terms of its multi−system involvement and complex pathological mechanisms. Academician Tong Xiaolin's "State−Target Medicine" provides a precise paradigm for integrated Chinese and Western medicine, emphasizing "macro−level state regulation and micro−level target intervention". Professor Jiang Quan's theory of "Body−Viscera Combined Obstruction" profoundly reveals the patterns of disease transmission and mutual damage between the "body" external physical forms, meridians, and blood vessels and the "viscera" internal organ systems. This article introduces this theory into the prevention and treatment system of EH within the State−Target Medicine framework, systematically explaining its pathogenesis and new diagnostic and therapeutic approaches. It is proposed that the core pathogenesis of EH lies in "meridian obstruction" as the form and "disharmony between the body and viscera" as the root. The key pathological factors involve abnormalities in the metabolism and distribution of qi, blood, water, and fire, forming core pathological states such as "congestion", "water", "stagnation", "cold", and "aging", which persist throughout the entire disease progression of "affecting qi and blood − affecting meridians − affecting viscera". In terms of treatment, the general principle of "harmonizing and balancing" is followed, with "simultaneous treatment of the body and viscera" as the guiding principle. At the macro level, the state is regulated by harmonizing qi and blood and dredging meridians; at the micro level, "target drugs" with proven antihypertensive and vascular function−improving effects are selected based on modern pharmacology. For example, for the "congestion state" characterized by gastrointestinal excess heat and turbid qi ascending, Houpu Sanwu Decoction is used to unblock the fu organs and dispel turbidity, combined with Cassia seed and hawthorn; for the "water state" characterized by internal retention of water−dampness, Danggui Shaoyao Powder is used to strengthen the spleen and promote diuresis, combined with Poria and Leonurus; for the "stagnation state" characterized by liver qi stagnation and transformed fire flaming upward, Sini Powder is used to disperse and relieve stagnation, combined with Prunella and Uncaria; for the "cold state" characterized by cold congealing in the meridians and contraction and spasm, Gegen Decoction is used to dispel cold and unblock collaterals, combined with Pueraria and cinnamon twigs; for the "aging state" characterized by kidney essence deficiency and meridian hardening, Duhuo Jisheng Decoction is used to tonify and unblock collaterals, combined with Eucommia and Achyranthes. By constructing a state−target differentiation and treatment system for EH based on the "Body−Viscera Combined Obstruction" theory, this article provides a theoretical basis and practical path for enhancing the systematic and precise prevention and treatment of hypertension with traditional Chinese medicine.

body−viscera combined obstruction  /  state−target medicine  /  essential hypertension  /  traditional Chinese medicine
Nan JIANG, Ciming PAN, Hui FANG, Changwu DONG. The theory of "body−viscera combined obstruction" from the perspective of state−target medicine and its clinical application in essential hypertension[J]. Science & Technology Review, 2026 , 44 (13) : 151 -156 . DOI: 10.3981/j.issn.1000-7857.2025.12.00004
Year 2026 volume 44 Issue 13
PDF
94
41
Cite this Article
BibTeX
Article Info
doi: 10.3981/j.issn.1000-7857.2025.12.00004
  • Receive Date:2025-12-04
  • Online Date:2026-07-27
  • Published:2026-07-13
Article Data
Affiliations
History
  • Received:2025-12-04
  • Revised:2026-06-18
Funding
Affiliations
    1College of Traditional Chinese Medicine, Anhui University of Chinese Medicine, Hefei 230038, China
    2School of Life Sciences, Yunnan University, Kunming 650500, China
    3Yunzhongdao Yunnan Traditional Chinese Medicine Great Health Co., Ltd., Kunming 650500, China
    4The Second Affiliated Hospital of Anhui University of Chinese Medicine, Hefei 230038, China
References
Share
https://castjournals.cast.org.cn/joweb/kjdb/EN/10.3981/j.issn.1000-7857.2025.12.00004
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT